Lochmüller Lab seeking PhD student

The Lochmüller Research Group are seeking a highly motivated PhD student to join our team at the Childrens Hospital of Eastern Ontario Research Institute (CHEO RI). The project, part of the recently funded Brain-Heart Initiative at uOttawa, will involve working with advanced cell models to perform drug screens, biomarker studies, and mechanistic investigations into Myotonic Dystrophy Type 1 (DM1). Candidates with previous laboratory experience, particularly in cell culture and molecular biology are particularly encouraged to apply.

Check out the full description of the PhD opportunity.

Research Environment

The Lochmüller Research Group specializes in conducting scientific, genetic, and clinical investigations into neuromuscular disorders, while also providing clinical support for individuals affected by these conditions. Our primary objective is to unravel the reasons behind genetic variations in the human genome give rise to these often debilitating, and occasionally life-threatening disorders that impact the muscles and nervous system. Employing a translational approach from laboratory research to practical applications, we identify genetic defects in patients through in-depth phenotyping and next-generation sequencing. Subsequently, we delve into understanding molecular pathways using cell and animal models before progressing to preclinical and clinical trials testing innovative targeted therapies. The CHEO Research Institute is located in Ottawa, sharing a campus with the University of Ottawa, The Ottawa Hospital Research Institute, and the CHEO hospital. This arrangement fosters valuable collaboration among various groups, facilitating the exchange of resources and equipment. Ottawa provides a vibrant, inclusive, cost-effective, and friendly atmosphere for both academic pursuits and daily life. Additionally, the city benefits from excellent transportation links, both internally and to other Canadian cities.

Entry Requirements

Candidates are expected to hold or be about to obtain a MSc degree in a related subject/area. In addition, to selection by the Lochmüller Research group, candidates will need to apply to The University of Ottawa CMM program and fulfil their entry requirements.

How to Apply

If you are interested, please send you CV, Transcripts, and cover letter explaining why you are interested in this opportunity to Dr Sally Spendiff at . Applications should be submitted by the 8th of March. 

 

Copy of Lochmuller Lab - PhD opportunity (LLab)

Read next...

New publications alert

New Publications Alert!

Our group has recently published two new papers with the first providing insights on the impact of GFPT1 loss in cellular models and the second...
New members post - July 2026

Meet The Lochmüller group’s Newest Members!

Our group is growing! We are excited to introduce two new members who have recently joined the Lochmüller group. Claudia Wyld Clinical Research Assistant Claudia...
Kelly and Ofosu papers (4)

New Publication: Gene-specific response to muscle specific kinase agonist antibody in the treatment of congenital myasthenic syndromes

Congenital myasthenic syndromes (CMS) are a group of rare inherited neuromuscular disorders. Although many forms of CMS appear similar clinically, the disease can be caused...
PDF position with Kiran-2

We are recruiting: Postdoctoral Fellow in Rare Disease Bioinformatics

The Polavarapu research group is recruiting a Postdoctoral Fellow in Rare Disease Bioinformatics. Working within a multidisciplinary and collaborative research environment, the postholder will provide...
Adobe Express - file

Oral Platform Presentation (Undergraduate) Category Winner!

We are thrilled to share that Katerina was the winner of Undergraduate Category for her presentation titled “Novel gene discovery in congenital myasthenic syndromes using optogenetic zebrafish...
haleyozgefinal

Two Research Lab Members Receive CIHR Funding Awards!

We are excited to share that two of our research team members have received competitive funding awards from the Canadian Institutes of Health Research (CIHR)...